For: | Sharif NA, Patil R, Li L, Husain S. Human ciliary muscle cell responses to kinins: Activation of ERK1/2 and pro-matrix metalloproteinases secretion. World J Ophthalmol 2016; 6(3): 20-27 [DOI: 10.5318/wjo.v6.i3.20] |
---|---|
URL: | https://www.wjgnet.com/2218-6239/full/v6/i3/20.htm |
Number | Citing Articles |
1 |
Najam A. Sharif. Handbook of Basic and Clinical Ocular Pharmacology and Therapeutics. 2022; : 251 doi: 10.1016/B978-0-12-819291-7.00032-0
|
2 |
Najam A. Sharif. Therapeutic Drugs and Devices for Tackling Ocular Hypertension and Glaucoma, and Need for Neuroprotection and Cytoprotective Therapies. Frontiers in Pharmacology 2021; 12 doi: 10.3389/fphar.2021.729249
|
3 |
Najam A. Sharif. Identifying new drugs and targets to treat rapidly elevated intraocular pressure for angle closure and secondary glaucomas to curb visual impairment and prevent blindness. Experimental Eye Research 2023; 232: 109444 doi: 10.1016/j.exer.2023.109444
|
4 |
Najam A. Sharif. Discovery to Launch of Anti-allergy (Emadine; Patanol/Pataday/Pazeo) and Anti-glaucoma (Travatan; Simbrinza) Ocular Drugs, and Generation of Novel Pharmacological Tools Such as AL-8810. ACS Pharmacology & Translational Science 2020; 3(6): 1391 doi: 10.1021/acsptsci.0c00137
|